Miromatrix Medical Inc.
USD3.39
+0.02 (+0.59%)
CEO
Jeffrey James Ross
IPO Date
2021-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.38
Prev. Close
$3.37
Day Low
$3.36
Day High
$3.53
52W Low
$0.91
52W High
$4.35
Market Cap
$0.09B
Volume
0.63M
| -6.4 |
| 31 Dec 2020 | FY | -974.6% | -18732.7% | 17.1% | -165.9% | -0.14 | 0.57 | -18.5 |
| 31 Dec 2019 | FY | 0.0% | -1228.1% | 7.4% | -39.6% | -0.03 | 2.39 | -52.0 |
| -1.8 |
| 31 Mar 2023 | Q1 | -1466.2% | -90091.8% | -25.9% | -21.0% | 0.12 | 8.22 | -1.3 |
| 31 Dec 2022 | Q4 | 86.6% | -746.6% | -26.6% | -20.0% | 0.14 | 5.52 | -2.2 |
| 30 Sept 2022 | Q3 | -908.5% | -60506.8% | -22.9% | -18.5% | 0.11 | 8.09 | -3.1 |
| 30 Jun 2022 | Q2 | -3063.0% | -207039.2% | -20.4% | -17.2% | 0.09 | 9.09 | -2.5 |
| 31 Mar 2022 | Q1 | -1746.9% | -106438.4% | -15.2% | -13.4% | 0.08 | 18.54 | -2.8 |
| 31 Dec 2021 | Q4 | -1462.5% | -68450.0% | -10.1% | -9.0% | 0.02 | 12.12 | -4.4 |
| 30 Sept 2021 | Q3 | -1173.0% | -51508.1% | -8.5% | -7.9% | 0.01 | 17.58 | -6.9 |
| 30 Jun 2021 | Q2 | -1267.8% | -40516.8% | -5.8% | -5.5% | 0.01 | 27.16 | -14.9 |